The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Peptide receptor radionuclide therapy (PRRT) is an important therapeutic option for somatostatin receptor (SSTR) positive metastatic and/or inoperable neuroendocrine tumours (NETs). However, in patients with poorly controlled carcinoid syndrome, it may lead to an acute flare of carcinoid symptoms or even carcinoid crisis. We report seven patients who received PRRT with (177Lu-DOTA0, Tyr3) octreotate...
Neuroendokrine Tumoren (NET, vormals „Karzinoide“) des Ileums und Jejunums sind benigne oder unterschiedlich agressiv wachsende maligne Tumoren. Sie treten oft multipel auf. Koinizidierende nichtneuroendokrine Karzinome des GI-Trakts sind häufig. Symptome entstehen durch regionale Lymphknotenmetastasierung, Durchblutungsstörungen des Darms, Raffung des Mesenteriums und ggf. Hormonbildung. NET der...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.